PTCOG 54
2nd Annual PTCOG-NA
San Diego
Report to the General Assembly
of PTCOG
Eugen B. Hug, MD
Chair
May 21, 2015
PTCOG
World wide Statistics 2014
Particle Therapy Worldwide – 2014 Survey by PTCOG
Number of Patients treated with Particle Therapy* worldwide as of End
2014:
49 Centers operational
Total of all facilities (in and out of operation):
He
2054
1957-1992
Pions
1100
1974-1994
C-ions
157369
1994 -
433
1975-1992
Protons
118181
1954 -
Grand Total
133931
Other ions
* Data collection = voluntary reporting by particle centers
Facilities in Clinical Operation and
No. of Patients Treated 1955-2014
140000
60
50
No. of Patients Treated
120000
100000
80000
60000
40
30
20
40000
20000
0
10
No. of Facilities in Clinical Operation
160000
Patients
Facilities
0
Ref.: PTCOG, 2015
From: M. Jermann, Annual PTCOG Survey 2014
Patients Treated with Protons and C-ions
in North America, Asia and Europe
Total number of patients (cumulative)
70000
60000
50000
40000
North America, Protons
Japan/China/Korea, Protons
30000
Japan/China/Korea, C-ions
Europe/Russia, Protons
20000
Europe/Russia, C-ions
10000
0
Ref.: PTCOG, 2015
From: M. Jermann, Annual PTCOG Survey 2014
Patients Treated with Protons and C-ions Worldwide
Total number of patients (cumulative)
120000
100000
80000
60000
World, Protons
World, C-ions
40000
20000
0
Ref.: PTCOG, 2015
From: M. Jermann, Annual PTCOG Survey 2014
Patients Treated with Particles 1954-2014
He, Pions &
Others
3%
C-ions
11%
Protons
86%
Total 137504 patients :
Protons 118181 pts.
Carbon
15736 pts.
From: M. Jermann, Annual PTCOG Survey 2014
Patients Treated during the year 2014,
Protons and C-ions
Asia, Cions
13%
Asia, Protons
19%
Europe, C-ions
4%
Europe,
Protons
20%
North
America,
Protons
44%
Total 15432 patients :
Protons 12863 pts.
Carbon
2555 pts.
= approx. 80% Protons : 20% Carbon Ions
From: M. Jermann, Annual PTCOG Survey 2014
PTCOG 54 / PTCOG-NA
Conference Information
Registration Statistics
Registration
Numbers
EW SM
Educational Session Only (ES)
85
EW SM
Scientific Meeting (SM)
516
Both
383
TOTAL
984
Registration Statistics
Attendance in previous meetings
EW SM
EW SM
PTCOG 51
Seoul
PTCOG 52
Essen
PTCOG 53
Shanghai
PTCOG 54
San Diego
Educational
Workshop (EW)
448
472
582
468
Scientific Meeting
(SM)
627
734
542
899
-
72
-
-
706
887
832
984
RTT Workshop
TOTAL
Country Distribution PTCOG-54
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Country
AUSTRALIA
AUSTRIA
BELGIUM
CANADA
CHINA
CZECH REPUBLIC
DENMARK
EGYPT
FINLAND
FRANCE
GERMANY
HONG KONG, CHINA
INDIA
ISRAEL
ITALY
JAPAN
Brasil
NEW ZEALAND
NORWAY
POLAND
Paid
2
10
11
4
17
8
7
1
4
14
39
9
3
2
9
75
1
1
6
10
21
REPUBLIC OF KOREA
20
No.
Country
Paid
22
Turkey
3
23
RUSSIA
2
24
SAUDI ARABIA
1
25
SINGAPORE
5
26
SOUTH AFRICA
1
27
SWEDEN
5
28
SWITZERLAND
22
29
TAIWAN
18
30
THAILAND
2
31
THE NETHERLANDS
8
32
UK
33
33
USA
377
TOTAL:
33 countries
969 participants
27.0%
52.3%
20.7%
Africa/Americas
Asia/Pacific
Europe/MidEast
PTCOG
Infrastructure
Committees
Statutes
PTCOG-Committees:
Present Committees:
Publication Committee
Co-Chairs: H. Giap, E. Blomquist, Representative of IJPT Editorial
Board
Education Committee
Co-Chairs: Z. Tochner, J. Flanz
Scientific Program Committee
Co-Chairs: A. Mahajan. M. Vazquez, A. Lomax
“PTCOG Bylaws / Statutes Task Force”
Corporate Relations Task Force
PTCOG-Committees:
Clinical Disease Site Sub-Committees:
Pediatric Committee
Co-Chairs: A. Mahajan, JY Kim, plus European Representative
Thoracic Malignancy / Lymphoma Committee
Co-Chairs: J. Chang, T. Lomax, B. Hoppe
Ophthalmic Committee:
Co-Chairs: J. Hrbacek, A. Kacperek, K. Mishra
Other Initiatives?
Please, contact [email protected] for participation
PTCOG Executive Committee Meeting – PTCOG-54
PTCOG-Statutes and Bylaws
 Mandate from Steering Committee to Executive Committee in 2014: Update
 Action by Executive Committee:
Updated Statutes, concentrated on most urgent / important topics
For more detailed update “Statutes Task Force” to continue work
throughout the year.
 Action by Steering Committee: Approval 5/20/2014
Statutes of the
Particle Therapy Co-operative Group (PTCOG)
The Executive Committee proposes the following Amendments to the
Steering Committee at PTCOG-54, 5/20/2015:
The Terms of all leadership positions shall be 3 years with the
possibility of one re-election, thus limiting any position to
maximally 2 terms.
This includes:
Chair and Vice-Chairs of PTCOG
Executive Committee Members
SubCommittee Chairs and Co-Chairs
Statutes of the
Particle Therapy Co-operative Group (PTCOG)
The Executive Committee proposes the following Amendments to the
Steering Committee at PTCOG-54, 5/20/2015:
Article 8
Meetings of the Association
……
……
8.3 The Host Institution of the Meeting shall be fully responsible for the overall
organization of the Meeting and for financial and other resources needed for
the organization and operation of the Meeting. The program of both, the
educational meeting as well as scientific meeting shall be organized by the
Educational Sub-Committee and the Scientific Program Sub-Committee,
respectively, in coordination with the Host, and approved by the Executive
Committee.
Statutes of the
Particle Therapy Co-operative Group (PTCOG)
The Executive Committee proposes the following Amendments to the
Steering Committee at PTCOG-54, 5/20/2015:
Article 14
Chairmanship of PTCOG; Term, Duties and Powers
14.1
The Chairmanship of the Association shall be composed of
a Chairperson. In addition two Vice-Chairpersons shall be elected.
Chair and Vice-Chairs shall represent three Continents.
14.5
The term of office for the Chairperson and for the two
Vice-Chairpersons shall be 3 years. Re-appointment for another 3
years shall be possible. The maximum term of the Chairperson and
the two Vice-Chairpersons shall be limited to 2 terms total.
Statutes of the
Particle Therapy Co-operative Group (PTCOG)
The Executive Committee proposes the following Amendments to the
Steering Committee at PTCOG-54, 5/20/2015:
Article 15
Executive Committee, Composition and Term
15.1 The Executive Committee shall consist of:
(a) The Chairperson and the two Vice-Chairpersons of the Steering Committee;
(b) The past Chairperson of the Steering Committee;
(c) The 2 Co-Chairpersons of the Educational Sub-Committee;
(d) The 3 Co-Chairpersons of the Scientific Program Sub-Committee;
(e) One Chairperson of the Publication Sub-Committee
(f) One Representative of the Clinical Sub-Committees appointed by the Executive
Committee to represent the Clinical Sub-Committees;
(g) The Secretary of PTCOG.
15.3 The term of office for each member of the Executive Steering Committee shall be
3 years. Re-appointment for one additional term shall be possible.
Statutes of the
Particle Therapy Co-operative Group (PTCOG)
The Executive Committee proposes the following Amendments to the
Steering Committee at PTCOG-54, 5/20/2015:
Article 17
Sub-Committees; Composition, Term, Duties and Powers
17.1 Sub-Committees shall be implemented for special activities and tasks, which are of special
and continued interest, in particular a Scientific Program Sub-Committee, an Educational SubCommittee, a Publication Sub-Committee and Clinical Sub-Committees for exchanging
experience in clinical and technical issues.
17.2 Sub-Committees can be proposed by Members by written application to the Executive
Committee. The implementation of a Sub-Committee has to be approved by the Steering
Committee.
17.3 The Sub-Committees are chaired and co-chaired by members proposed by the Executive
Committee and elected by the Steering Committee. All Members of the Association can apply
to the Chairperson of the Sub-Committee to join.
17.4 The term of office for Chairperson and for Co-Chairpersons of the Sub-Committees shall
be 3 years. One Re-appointment for another 3 years shall be possible.
Statutes of the
Particle Therapy Co-operative Group (PTCOG)
The Executive Committee proposes the following Amendments to the
Steering Committee at PTCOG-54, 5/20/2015:
17.5 The Sub-Committees have the following powers and duties:
(a) Organize and execute programs approved as needed by the Steering Committee;
(b) ..
(c) report annually to the Executive Committee and Steering Committee.
17.6 Sub-Committees shall be dissolved at the discretion of the Steering Committee by simple
majority vote.
…much more work to be done
….by the Task Force
PTCOG
Honorary Members
Andi Koehler
PTCOG
Honorary Members
Newly elected:
Gudrun Goitein, MD
Paul Scherrer Institute, Switzerland
Erik Blomquist, MD
Svedberg Laboratory, Uppsala, Sweden
•
New Members of the Steering Committee
•
•
•
•
•
•
•
•
•
Hokkaido University Hospital Proton Therapy Center, Sapporo, Japan
University of Texas Southwestern Proton Therapy Center; Dallas, USA
University of Maryland Proton Treatment Center, Baltimore, USA
University of Cincinnati Healt PTC, Cincinnati, USA
KIRAMS, South Korea
National Taiwan University CC, Taipei, Taiwan
Apollo Hospitals, Chennai, India
UCLH, NHS Founndation Trust, London, UK
PTCOG Finances, Approval
(December 31, 2014)
We have CHF 206’178.45 on our bank account
which is about $ 219’000 (2013: $ 213’500) or
about € 197’100 (2013: € 160’400)
(depending on actual exchange rates)
The balance sheet and the audit report are published on the
PTCOG website (http://www.ptcog.ch/index.php/sc-reports)
PTCOG 54, San Diego, May 2015
PTCOG Finances, Approval (CHF)
(Assets 31.12.2014 & Budget 2015)
Total assets
Income
Balance of PTCOG Meetings
PTCOG 53 IMPT-Symposium
Advertisements
Interest
Total Income
31.12.2014
206'178.45
Budget 2015
28'953.02
34'701.60
30'000
494.56
64'149.18
5'000
400
35'400
Expenses
28'505.15
PTCOG 53 IMPT-Symposium
21'323.20
Int. Journal of Particle Therapy
Net Exp.Travel Fellowship Program 352.90
285.50
Other Expenses (Audit, IT...)
50'466.75
Total Expenses
20'000
3000
5000
28'000
13'682.43
7'400
Profit for the year
PTCOG 54, San Diego, May 2015
PTCOG
Travel Fellowship Program
Purpose: Grants to support young scientists working in particle
therapy to travel to the PTCOG conference
This year 14 (out of 25) applicants from 9 countries got an award
of $ 500 - $ 1’500; $ 18’500 we spend for PTCOG 54;
We need more support from Sponsors for this program!
Thanks to the contributors (IBA, Schär Eng.) for the kind and
continues support of this program! More companies should join.
PTCOG 54, San Diego, May 2015
PTCOG
Travel Fellowship Program
To apply, an applicant must:
• not have received a PTCOG travel fellowship previously
• be at most 5 years beyond his or her highest degree and with at least one-half
a year’s, and at most 3 year’s, experience in particle beam therapy;
• be a member of, or at least loosely affiliated with, an institution which must
either: have, be building, or be in advanced stages of planning, of a medical
particle therapy facility.
• and, whose institution will undertake to cover any additional costs of a fellow’s
attendance at the society’s meeting.
Abstract submitted and accepted (not a ‘must’, but favored, if too many appl.)!
PTCOG 54, San Diego, May 2015
PTCOG Travel Fellowship Program
List of Participants PTCOG 54
Ahmad, Reem
PhD, Medical Physics
UCL London, UK
Ciurlia, Elisa
MD
C.N.A.O, Pavia, Italy
Kim, Dae-Hyun
PhD, Medical Physics
Samsung Medical Center, Seoul, South
Korea
Landry, Guillaume
PhD, Medical Physics
LMU, Munich, Germany
Lindsay, Clay
PhD Student, Medical Physics
TRIUMF, Vancouver, Canada
PTCOG 54, San Diego, May 2015
PTCOG Travel Fellowship Program
List of Participants PTCOG 53
Lowe, Matthew
PhD Student, Medical Physics
The Christie NHS Foundation Trust,
Manchester, UK
Magallanes, Lorena
PhD Student, Medical Physics
Univ. of Heidelberg / HIT, Heidelberg,
Germany
MaKarova, Anastasia
PhD, Medical Physics
ITEP, Moscow, Russia
Peroni, Marta
PhD, Medical Physics
CPT, PSI, Villigen, Switzerland
PTCOG 54, San Diego, May 2015
PTCOG Travel Fellowship Program
List of Participants PTCOG 53
Rana, Suresh
MSc Medical Physics
Procure PTC, Oklahoma, USA
Tessonier, Thomas
PhD Student, Medical Physics
DKFZ, Heidelberg /LMU Munich, Germany
Warren, Samantha
PhD Student, Medical Physics
Yu, Juan
PhD, Medical Physics
Zhang, Xiaomeng
MD
Univ. of Oxford, Dep.of Oncology, Oxford,
UK
MD Anderson PTC, Houston, TX, USA
Shanghai Proton and Haevy Ion Center,
Shanghai, China
PTCOG 54, San Diego, May 2015
PTCOG
Travel Fellowship Program
We invite all industrial companies to support our
Travel Fellowship Program for PTCOG 55.
Thank you for this kind support!
PTCOG 54, San Diego, May 2015
PTCOG-North America
Update at PTCOG-54
Steering Committee Meeting,
San Diego
Eugen B. Hug
PTCOG:
Scientific exchange
Education
Global networking and update
Global industry update
International Journal /Publications
“World Congress of Particle Therapy”
National / continental “chapters”
or independent societies
PTCOG- North America
Japan Clinical
Study Group of
Particle Therapy
(JCPT)
Scientific Exchange
Education
Health Care Policy
Patient Advocacy
Interface with RTOG / ASTRO
Structured membership with
fees
Europe ?
PTCOG-NA Membership (171)
Full
110
64% Physicians
36% Physicists
0% Radiobiologists
Associate
34
0
3
12
14
2
1
1
1
In Training
6
6
Not Specified
Physicians (Residents)
21
21
TOTAL MEMBERS
Physician
Medical Physicist
Medical Dosimetrist
Radiation Therapist
Consultant
Administrator
Research
Other
171
X
October 27-29, Houston, TX
PTCOG NA 2014
Start Times
7:30
8:00
8:30
Sunday Oct 26
9:00
9:30
10:00
10:30
11:00
11:30
12:00
12:30
1:00
1:30
2:00
2:30
3:00
3:15
3:30
4:00 PROTON CENTER TOUR sign up
4:30
5:00
5:30
6:00
7:00
8:00
9:00
Monday Oct 27
SUNRISE SessionHead and Neck
Tuesday Oct 28
Wednesday Oct 29
SUNRISE Session
Breast, Intact and CW
SUNRISE Session
GastroIntestinal
Scientific Session
Scientific Session
BREAK
BREAK
Welcome
Scientific Session
BREAK
Clinical Trial Session Lung and
Esophagus
Clinical Trial Session GU, Clinical Trial Session Appropriate
Hypofractionation
Endpoints
Lunch
Challenging Cases Planning
General Assembly
Lunch
Challenging Cases Medical
Break
Poster Viewing
Scientific Session
Keynote
Soren
Bentzen
Debate
All
Scanning?
Break
Oral Poster Session
Executive Meeting
Reception
Texas Extravagana, Armadillo
Palace
Closing
ADJOURN
Registration
Total
Pre-Registered
262-72
61 Institutions
212
On-Site Reg
10-15
Sponsor Rep
45
16 companies
General Assembly Vote (members only):
Value of PTCOG-NA for its membership
-choose 2nd highest priority
A:
CME’s from Annual Meetings/Seminars
B:
SAM’s / MOC
C:
Educational Seminars “Basic”
D:
Educational seminars “Disease-Specific”
E:
Educational Seminars “Master Class”
“First Announcement”
SEMINAR SERIES ON ADVANCED CLINICAL PARTICLE THERAPY
“The Emerging Role of Proton Therapy in
Head & Neck Tumors”
WHEN + WHERE
September 28 – 29, 2015, Monday & Tuesday
The Boulders – A Waldorf Astoria Resort
Scottsdale/ Carefree, Arizona
CHAIRS
Eugen B. Hug, MD
William Hartsell, MD
FACULTY
Annie Chang, MD
Roi Dagan, MD
Steven J. Frank. MD, MS
Nancy Y. Lee, MD
Alexander Lin, MD
William Mendenhall, MD
Upendra Parvathaneni, MD
President, PTCOG - NA
Chair, Educational Committee, PTCOG – NA
Massachusetts General Hospital
University of Florida
MD Anderson Cancer Center
Memorial Sloan-Kettering Cancer Center
University of Pennsylvania
University of Florida
University of Washington
“Continental’ PTCOG chapters: Complimentary and not competitive to
PTCOG-global
(as much as realistically possible)
PTCOG- North America
Scientific Exchange
Education
Health Care Policy
Patient Advocacy
Interface with RTOG /
ASTRO
Annual conference - combined with
PTCOG if in the US. Provide a scientific
platform for junior and mid level
investigators who can not afford travels
to other continents.
“Sunrise Session” during annual meeting
Advanced clinical seminars
Letters of support
In development
International Journal of Particle Therapy
The images used in the journal
cover are courtesy of Ioannides
et al.
HOMEPAGE
Table of
Contents
Volume 1
Issue 4
Announcements
• IJPT is one year old
• A special topic issue on carbon ions is
expected to be published later this year
• Meeting proceedings from PTCOG54 will be
published in the summer issue
• New Associate Editors:
• Lei Dong, PhD (Scripps Proton Therapy
Center)
• Marco Durante (GSI Helmholtzzentrum fur
Schwerionenforschung)
• Hsiao-ming Lu (Massachusetts General
Hospital)
Indexing and Impact Factors
• We are currently listed in Google Scholar
• We will be pursuing other indexing
opportunities this year, most notably
PubMed Central and MEDLINE
• if you have any experience applying for PubMed
indexing through another journal, or if you know of
anyone associated with the National Library of
Medicine's Library Operations Division, we would
appreciate your insight on this process
• We have applied to Thomson Reuters for an
impact factor
Advertising
• The Associate Editors have approved
advertising on the IJPT website
• The addition of advertising will offset costs
associated with keeping IJPT an open
access journal with no fees for the authors or
readers
• Our first advertiser is IBA!
Website Statistics
• The official website for IJPT has attracted an
average of 600 visitors, 900 unique pageviews, and
2300 total pageviews per month
United States
38.44%
Brazil
5.83%
United Kingdom
5.37%
Germany
5.24%
Japan
China
4.75%
3.98%
Sweden
3.27%
Italy
3.20%
Poland
Switzerlan
0.00%
Total Sessions = 8,804
2.87%
2.25%
5.00%
10.00% 15.00% 20.00% 25.00% 30.00% 35.00% 40.00% 45.00%
Corresponding Authors:
Countries of Origin
Total = 53
United States
Germany
Sweden
Belgium
China
Japan
Russia
Switzerland
United Kingdom
79.20%
5.66%
3.77%
1.89%
1.89%
1.89%
1.89%
1.89%
1.89%
0.00% 25.00% 50.00% 75.00% 100.00%
Manuscript Submissions:
Classifications
Total = 53
Clinical
69.81%
Physics
0.00%
30.19%
20.00%
40.00%
60.00%
80.00%
Manuscript Submission: Article Type
Total = 53
Original Articles
Reviews
Case Reports
84.91%
9.43%
5.66%
0.00% 25.00% 50.00% 75.00% 100.00%
Note: More review articles means a higher impact factor!
Editorial Board Statistics
Editorial Statistics
Manuscripts submitted
Manuscripts accepted
Reviewers involved
Revisions required for acceptance
53
32
116
1 (range, 0 to 2)
Associate Board Statistics
No. of assignments per editor
No. of decisions made
No. of reviewers utilized
7.75 (range, 2-13)
6.88 (range, 2-13)
12.25 (range, 2-26)
Hosting PTCOG:
• PTCOG-55:
Prague 2016
• PTCOG-56:
Yokohama City 2017
Hosting PTCOG 2018:
• PTCOG-57:
Cincinnati, USA
Proton
Therapy
Center
Cincinnati Children’s
• Consistently, one of the top 3 children’s hospitals
in cancer, according to US News and World
Report
• One of only two children’s hospitals
nationally ranked in all pediatric
subspecialties
• Top 3 children’s hospital in terms of NIH
funding; $340 million / year
• One of largest private basic biological science
research groups in the world
• 116,000 animals live at CCHMC!
• Formal basic science / radiation biology
particle therapy research collaboration with
Heidelberg Ion Beam Therapy Center
University of Cincinnati
• 40,000 students and over 6000 faculty
making it one of the largest universities in
Ohio
• Top 3 “Up and Coming Universities”
according to US News and World Report
• Research “clusters” are being formed by the
University to support the research mission
• The Proton Therapy Center is directly
responsible for driving these “cluster”
formations
• Notable Alumni:
• Albert Sabin, oral polio vaccine
• Neil Armstrong, first man on the moon
• William H. Taft, 27th President of USA (19091913)
Hosting PTCOG:
• PTCOG-55:
Prague 2016
UPDATE
PTCOG-54
Elections for 2015 - 2018
Chair
Vice-Chair
Vice-Chair
Secretary/Treasurer
PTCOG-54
Elections for 2015-2018
Chair
Jay Flanz, PhD
USA
Vice-Chair
Marco Durante, PhD
Germany
Vice-Chair
Tadashi Kamada, MD
Japan
Secretary/Treasurer Martin Jermann, MSc
Switzerland
Thank you !